Drawing for FENBENDAZOLE+ 444MG LAB TESTED| PURITY>99% 90 CAPSULES

USPTO serial 99417673

FENBENDAZOLE+ 444MG LAB TESTED| PURITY>99% 90 CAPSULES

Status 641Office Action
Filing date
Sep 29, 2025
Status date
Jul 27, 2026
Registration date
Examiner
BECHHOFER, YOCHEVED D

Need help with FENBENDAZOLE+ 444MG LAB TESTED| PURITY>99% 90 CAPSULES?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: 27 Oct 2026

Office Action issues

The USPTO examiner refused your color trademark because the colors are not inherently distinctive and the white color is considered functional, requiring drawing updates and additional product information.

Owner

  • Le Pierre Home

    glendale, CA, US

Goods and services

ClassDescriptionStatusFirst use
005Probiotic supplements; Vitamin supplements; Food supplements; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of viral diseases; Prebiotic supplements; Nutritional supplements; Mixed antibiotic preparations; Pharmaceutical products for the treatment of viral diseases; Biological preparations for the prevention and treatment of broad spectrum warm, parasitic infections, allergic reactions, viral infections, viral diseaseACTIVEJan 1, 2025

Prosecution history

DateCodeEvent
Jul 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 27, 2026GNRTNON-FINAL ACTION E-MAILED
Jul 27, 2026CNRTNON-FINAL ACTION WRITTEN
Jul 9, 2026DOCKASSIGNED TO EXAMINER
Feb 23, 2026DOCKASSIGNED TO EXAMINER
Feb 20, 2026DOCKASSIGNED TO EXAMINER
Feb 19, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 19, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Sep 29, 2025NWAPNEW APPLICATION ENTERED

Related guidance